Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dobaczewski

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Vascular Pharmacology|July 29, 2009
Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activityCezary Watala, Marcin Dobaczewski, Piotr Kazmierczak, et al.
Circulation Research|October 2, 2013
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulationCarlos Gonzalez-Quesada, Michele Cavalera, Anna Biernacka, et al.
Circulation Research|October 3, 2009
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarctionMarcin Bujak, Marcin Dobaczewski, Carlos Gonzalez-Quesada, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia AL Nemes, T Lissitchkov, A Klukowska, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2008
Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectivenessMarcin Dobaczewski, Marek Nocun, Ilya Zavodnik, et al.
Acta Haematologica|February 29, 2008
Pharmacokinetics, efficacy and safety of IMMUNATE solvent/detergent (IMMUNATE S/D) in previously treated patients with severe hemophilia A: results of a prospective, multicenter, open-label phase III studyL Nemes, T Lissitchkov, G Dobaczewski, et al.
Physical Review Letters|October 10, 2006
E center in silicon has a donor level in the band gapA Nylandsted Larsen, A Mesli, K Bonde Nielsen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2013
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokineticsR Kulkarni, F A Karim, S Glamocanin, et al.
Circulation. Heart Failure|May 20, 2015
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic MiceAnna Biernacka, Michele Cavalera, Junhong Wang, et al.
Life Sciences|July 4, 2006
Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatmentE A Lapshina, E Ju Sudnikovich, Ju Z Maksimchik, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Vascular Pharmacology|July 29, 2009
Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activityCezary Watala, Marcin Dobaczewski, Piotr Kazmierczak, et al.
Circulation Research|October 2, 2013
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulationCarlos Gonzalez-Quesada, Michele Cavalera, Anna Biernacka, et al.
Circulation Research|October 3, 2009
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarctionMarcin Bujak, Marcin Dobaczewski, Carlos Gonzalez-Quesada, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia AL Nemes, T Lissitchkov, A Klukowska, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2008
Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectivenessMarcin Dobaczewski, Marek Nocun, Ilya Zavodnik, et al.
Acta Haematologica|February 29, 2008
Pharmacokinetics, efficacy and safety of IMMUNATE solvent/detergent (IMMUNATE S/D) in previously treated patients with severe hemophilia A: results of a prospective, multicenter, open-label phase III studyL Nemes, T Lissitchkov, G Dobaczewski, et al.
Physical Review Letters|October 10, 2006
E center in silicon has a donor level in the band gapA Nylandsted Larsen, A Mesli, K Bonde Nielsen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 9, 2013
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokineticsR Kulkarni, F A Karim, S Glamocanin, et al.
Circulation. Heart Failure|May 20, 2015
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic MiceAnna Biernacka, Michele Cavalera, Junhong Wang, et al.
Life Sciences|July 4, 2006
Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatmentE A Lapshina, E Ju Sudnikovich, Ju Z Maksimchik, et al.
Pageof 12